A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.

Source:http://linkedlifedata.com/resource/pubmed/id/19778210

Download in:

View as

General Info

PMID
19778210